SB 1833 directs Oklahoma's Department of Human Services to seek a federal waiver preventing SNAP (food stamp) benefits from being used to purchase candy and soft drinks, and to potentially exclude other "nonnutritive" foods. The department must submit a waiver request to the USDA with public health justification, an implementation plan for retail point-of-sale systems, and an education strategy for recipients. If approved, the restrictions would take effect within six months, requiring annual reports to state leaders on SNAP spending patterns and program impacts. This bill directly affects SNAP recipients in Oklahoma by changing eligible purchases and requires federal approval for implementation.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1290 allocates $3 million from Oklahoma's General Revenue Fund to maintain the state's 2-1-1 hotline for the 2027 fiscal year. The funding ensures the hotline continues providing direct support for basic needs like food, shelter, clothing, transportation, and medical assistance. This appropriation directly affects Oklahomans who rely on the 2-1-1 service for immediate help. The bill takes effect July 1, 2026.
HB 3329 extends the expiration date of Oklahoma's Long-Term Care Facility Advisory Board from July 1, 2025, to July 1, 2027. The bill modifies Oklahoma Statutes Section 1-1923 to continue the board's operation, which advises the State Commissioner of Health on long-term care services. The advisory board, composed of 13 members including healthcare professionals, facility operators, and public representatives, provides recommendations on care standards for nursing homes, residential care facilities, and adult day care centers. The bill takes effect July 1, 2026, as an emergency measure.
HB 4457 prohibits pharmacy benefits managers (PBMs) from owning or controlling pharmacy licenses in Oklahoma. The State Board of Pharmacy must revoke licenses of violators after November 2026, though it may issue temporary licenses for rare, orphan, or limited-distribution drugs until September 2028. Pharmacies must notify patients of service changes by January 2027, and the Board must provide lists of compliant pharmacies. This law prevents conflicts of interest by restricting PBMs from owning pharmacies.
This bill proposes a constitutional amendment to establish the "Tobacco Settlement Endowment Trust Fund" for Oklahoma's tobacco settlement funds. It requires that at least 75% of new tobacco settlement payments (after 2001) be deposited into this trust fund, with specific percentages increasing over time. The trust fund's earnings must be used for cancer research, tobacco prevention programs, children's health initiatives, senior care programs, and education-related expenses, with unused funds remaining in the trust. The amendment creates two governing boards to manage investments and allocate funds, and it would require voter approval before taking effect.
HB 4421 requires Oklahoma's Department of Human Services (DHS) to conduct a safety analysis within 24 hours when a child is suspected of being "drug-endangered" (e.g., due to fentanyl exposure or substance use by caregivers). It mandates drug screening - including mandatory fentanyl testing - for parents or caregivers when substance use is suspected, and allows DHS to seek court orders if consent is refused. The bill also creates a "Child Welfare Fentanyl Testing Revolving Fund" to cover testing costs and requires DHS to refer certain abuse/neglect cases to law enforcement. These provisions directly affect children in welfare cases, their caregivers, DHS staff, and local law enforcement agencies.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
HB 3345 requires mandatory mental health, substance abuse, and risk screenings for individuals arrested on felony charges in Oklahoma after their initial court appearance. These screenings, conducted by certified professionals from the Department of Mental Health, must be shared with courts, prosecutors, defendants, and their attorneys. Results cannot be used as evidence in criminal trials unless the defendant waives this right, but may inform sentencing or diversion options. The law takes effect November 1, 2026.
